Related references
Note: Only part of the references are listed.Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization
Alexander W. Tarr et al.
JOURNAL OF VIROLOGY (2012)
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
Erick Giang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Vaccination for hepatitis C virus: closing in on an evasive target
John Halliday et al.
EXPERT REVIEW OF VACCINES (2011)
Future hepatitis C virus treatment: interferon-sparing combinations
Edward Gane
LIVER INTERNATIONAL (2011)
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Jason S. McLellan et al.
NATURE (2011)
HEPATITIS IN 2010 The dawn of a new era in HCV therapy
Sandra Ciesek et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Robert Pejchal et al.
SCIENCE (2011)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert et al.
SCIENCE (2011)
The Hepatitis C Virus Glycan Shield and Evasion of the Humoral Immune Response
Francois Helle et al.
VIRUSES-BASEL (2011)
Mutations within a Conserved Region of the Hepatitis C Virus E2 Glycoprotein That Influence Virus-Receptor Interactions and Sensitivity to Neutralizing Antibodies
Simrat Dhillon et al.
JOURNAL OF VIROLOGY (2010)
Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt
F. DeWolfe Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule
Thomas Krey et al.
PLOS PATHOGENS (2010)
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
Teresa J. Broering et al.
JOURNAL OF VIROLOGY (2009)
HIV-1 and influenza antibodies: seeing antigens in new ways
Peter D. Kwong et al.
NATURE IMMUNOLOGY (2009)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies
Zhen-Yong Keck et al.
JOURNAL OF VIROLOGY (2008)
In vitro selection of a neutralization-resistant hepatitis C virus escape mutant
Meital Gal-Tanamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structure-based antigen design: a strategy for next generation vaccines
Philip R. Dormitzer et al.
TRENDS IN BIOTECHNOLOGY (2008)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Mansun Law et al.
NATURE MEDICINE (2008)
Determination of the human antibody response to the epitope defined by the hepatitis C virusneutralizing monoclonal antibody AP33
Alexander W. Tarr et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus
Daniel X. Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma
Pei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees
Gamal A. Elmowalid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
A Folgori et al.
NATURE MEDICINE (2006)
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity
DJ Schofield et al.
HEPATOLOGY (2005)
Towards rationalization of crystallization screening for small- to medium-sized academic laboratories: the PACT/JCSG plus strategy
J Newman et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2005)
Prospects for a vaccine against the hepatitis C virus
M Houghton et al.
NATURE (2005)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein
A Owsianka et al.
JOURNAL OF VIROLOGY (2005)
Protein structure prediction and analysis using the Robetta server
DE Kim et al.
NUCLEIC ACIDS RESEARCH (2004)
Share Paper
